Breaking news
President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients. It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States. Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more
Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings. ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
Doubts have been cast over the promising COVID-19 drug remdesivir that has shown ‘fantastic results’, after another study found it had no benefit. Remdesivir was reported by US officials to have ‘clear-cut’ evidence that it can help people recover from COVID-19, shortening the time of recovery. Dr Anthony Fauci, America’s top infectious disease expert, said … Read more
One of the doctors behind a promising remdesivir study, which shows it can be used as a treatment for COVID-19, has called it a ‘glimmer of hope’ and says he is now studying how to use the Ebola drug with other medications to give patients ‘tailored therapies’. His promising comments came on Thursday morning after … Read more
Doubts have been cast over the promising COVID-19 drug remdesivir that has shown ‘fantastic results’, after another study found it had no benefit. Remdesivir was reported by US officials to have ‘clear-cut’ evidence that it can help people recover from COVID-19, shortening the time of recovery. Dr Anthony Fauci, America’s top infectious disease expert, said … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
More than half of severely ill coronavirus patients treated with Ebola drug remdesivir recovered and were discharged from hospital within two weeks, trial results reveal Gilead Sciences treated 200 severely ill coronavirus patients with its Ebola antiviral remdesivir Regardless of whether they were treated for five or 10 days, more than half of the patients … Read more
Coronavirus hopes were today raised after the anti-viral remdesivir was found to help critically-ill patients recover within a week. University of Chicago Medicine recruited 125 people with COVID-19 as part of global clinical trials. Of those people, 113 had severe disease. All the patients were treated with daily infusions of remdesivir, an experimental drug first … Read more